TRADE-hypo (#1177)
Laufzeit: 01.01.2020 - 31.12.2040
imported
Kurzfassung
Thoracic Radiotherapy plus Durvalumab in Elderly - Employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy
Laufzeit: 01.01.2020 - 31.12.2040
Thoracic Radiotherapy plus Durvalumab in Elderly - Employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy